Anti-Apoptotic Effects of AMPA Receptor Antagonist Perampanel in Early Brain Injury After Subarachnoid Hemorrhage in Mice
Translational Stroke Research · 09.02.2023
DOI: 10.1007/s12975-023-01138-4 ↗Kurz gefasst
Fachartikel in der Zeitschrift Translational Stroke Research, online erschienen am 09.02.2023. Verfasst von Fumihiro Kawakita und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurosurgery, Mie University Graduate School of Medicine, 2-174 Edobashi, Mie , 514-8507, Tsu, Japan. Hauptthemen laut MEDLINE: Subarachnoid Hemorrhage, Brain Injuries, Nitriles, Pyridones. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 58 Literaturangaben. Gefördert von: Japan Society for the Promotion of Science, Sanikai Foundation, Taiju Life Social Welfare Foundation.
Abstract (Originalsprache)
This study was aimed to investigate if acute neuronal apoptosis is induced by activation of AMPA (α-amino-3-hydroxy-5-methyl-4-isoxazole propionate) receptors (AMPARs) and inhibited by a clinically available selective AMPAR antagonist and antiepileptic drug perampanel (PER) in subarachnoid hemorrhage (SAH), and if the mechanisms include upregulation of an inflammation-related matricellular protein periostin. Sham-operated and endovascular perforation SAH mice randomly received an administration of 3 mg/kg PER or the vehicle intraperitoneally. Post-SAH neurological impairments and increased caspase-dependent neuronal apoptosis were associated with activation of AMPAR subunits GluA1 and GluA2, and upregulation of periostin and proinflammatory cytokines interleukins-1β and -6, all of which were suppressed by PER. PER also inhibited post-SAH convulsion-unrelated increases in the total spectral power on video electroencephalogram (EEG) monitoring. Intracerebroventricularly injected recombinant periostin blocked PER's anti-apoptotic effects on neurons. An intracerebroventricular injection of a selective agonist for GluA1 and GluA2 aggravated neurological impairment, neuronal apoptosis as well as periostin upregulation, but did not increase the EEG total spectral power after SAH. A higher dosage (10 mg/kg) of PER had even more anti-apoptotic effects compared with 3 mg/kg PER. Thus, this study first showed that AMPAR activation causes post-SAH neuronal apoptosis at least partly via periostin upregulation. A clinically available AMPAR antagonist PER appears to be neuroprotective against post-SAH early brain injury through the anti-inflammatory and anti-apoptotic effects, independent of the antiepileptic action, and deserves further study.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Neurosurgery, Mie University Graduate School of Medicine, 2-174 Edobashi, Mie , 514-8507, Tsu, Japan.
- Department of Neurosurgery, Mie University Graduate School of Medicine, 2-174 Edobashi, Mie , 514-8507, Tsu, Japan. suzuki02@med.mie-u.ac.jp.
ORCID-Profile: Hidenori Suzuki
Förderung
- Japan Society for the Promotion of Science
- Sanikai Foundation
- Taiju Life Social Welfare Foundation
Zitieren
APA
Kawakita, F., Nakano, F., Kanamaru, H., Asada, R., & Suzuki, H. (2023). Anti-Apoptotic Effects of AMPA Receptor Antagonist Perampanel in Early Brain Injury After Subarachnoid Hemorrhage in Mice. Translational Stroke Research. https://doi.org/10.1007/s12975-023-01138-4
Vancouver
Kawakita F, Nakano F, Kanamaru H, Asada R, Suzuki H. Anti-Apoptotic Effects of AMPA Receptor Antagonist Perampanel in Early Brain Injury After Subarachnoid Hemorrhage in Mice. Translational Stroke Research. 2023. doi:10.1007/s12975-023-01138-4
BibTeX
@article{Kawakita2023,
author = {Kawakita, Fumihiro and Nakano, Fumi and Kanamaru, Hideki and Asada, Reona and Suzuki, Hidenori},
title = {Anti-Apoptotic Effects of AMPA Receptor Antagonist Perampanel in Early Brain Injury After Subarachnoid Hemorrhage in Mice},
journal = {Translational Stroke Research},
year = {2023},
doi = {10.1007/s12975-023-01138-4}
}
EUVIMED